Second failed referendum in five months has Arrowhead trying to figure out what's next
Arrowhead voters rejected a $136.2 million referendum April 1. The district is trying to figure out what's next.
Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) Shares Sold by Schroder Investment Management Group
Schroder Investment Management Group decreased its holdings in Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR – Free Report) by 1.2% during the 4th quarter, HoldingsChannel reports. The fund owned ...
Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) is favoured by institutional owners who hold 70% of the company
To get a sense of who is truly in control of Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR), it is important to understand the ownership structure of the business. We can see that institutions own the ...
A lawsuit alleges that Arrowhead Union High School is misrepresenting the costs associated with a $136M referendum
A lawsuit seeks to prevent Arrowhead from borrowing money for improvements to the campus, even if voters approve an April 1 referendum.
Arrowhead Pharmaceuticals (ARWR): Among the Most Oversold Healthcare Stocks to Buy Now
Plozasiran, obesity, and the central nervous system are key value drivers fueling growth from its internal development ...
Benzinga.com28d
Arrowhead Pharmaceuticals Stock Falls After Early-Stage Data From RNA-Based Therapeutic For Kidney Diseases
In January, the U.S. Food and Drug Administration accepted Arrowhead Pharmaceuticals’ New Drug Application for investigational plozasiran for familial chylomicronemia syndrome, a severe and rare ...